SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-006990
Filing Date
2022-03-16
Accepted
2022-03-16 16:31:03
Documents
72
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1992973
2 ex23-1.htm EX-23.1 3485
3 ex31-1.htm EX-31.1 12710
4 ex31-2.htm EX-31.2 12273
5 ex32-1.htm EX-32.1 8540
  Complete submission text file 0001493152-22-006990.txt   7697468

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE eton-20211231.xsd EX-101.SCH 51767
7 XBRL CALCULATION FILE eton-20211231_cal.xml EX-101.CAL 61228
8 XBRL DEFINITION FILE eton-20211231_def.xml EX-101.DEF 249631
9 XBRL LABEL FILE eton-20211231_lab.xml EX-101.LAB 462999
10 XBRL PRESENTATION FILE eton-20211231_pre.xml EX-101.PRE 356122
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1094100
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38738 | Film No.: 22745287
SIC: 2834 Pharmaceutical Preparations